Center for Scientific Review Notice of 11 Closed Meetings
Summary
The National Institutes of Health published a notice announcing 11 closed meetings of the Center for Scientific Review in May 2026. The meetings will review and evaluate grant applications across various research areas including biomedical informatics, blood-brain barrier studies, bacterial virulence, and clinical trials. Meetings are closed to the public under the Federal Advisory Committee Act provisions.
What changed
The NIH Center for Scientific Review published a Federal Register notice announcing 11 closed virtual meetings scheduled for May 2026. Each meeting involves a Special Emphasis Panel or review group evaluating grant applications across various biomedical and scientific research areas. Meetings are closed pursuant to the Federal Advisory Committee Act because discussions could disclose confidential trade secrets, commercial property such as patentable material, and personal information of individuals associated with grant applications.\n\nAffected parties include researchers and institutions applying for NIH grants that will be reviewed during these sessions. No public participation is permitted in these meetings; however, contact information is provided for each panel's Scientific Review Officer. Grant applicants should be aware that review discussions occur in confidential settings protected by federal law.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Notice
Center for Scientific Review; Notice of Closed Meetings
A Notice by the National Institutes of Health on 04/20/2026
PDF
Document Details
Document Dates
- Table of Contents
- Public Comments
- Regulations.gov Data
- Sharing
- Document Statistics
- Other Formats
- Public Inspection Published Document: 2026-07580 (91 FR 21010) Document Headings ###### Department of Health and Human Services
National Institutes of Health
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-23-145: NIGMS ESI-MIRA R35.
Date: May 7, 2026.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sudha Veeraraghavan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4166, Bethesda, MD 20892, (301) 827-5263, sudha.veeraraghavan@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Biomedical Informatics, Modeling and Data Science.
Date: May 13, 2026.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Alexander O. Komendantov, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 451-3397, alexander.komendantov@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Musculoskeletal Rehabilitation Sciences.
Date: May 14, 2026.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Aftab A. Ansari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4108, Bethesda, MD 20892, (301) 237-9931, ansaria@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Cellular and Molecular Aspects of the Blood-Brain Barrier and Neurovascular System and Therapeutic Strategies.
Date: May 14, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jessica Bellinger, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, (301) 827-4466, bellingerjd@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Endocrine and Metabolic Systems.
Date: May 14, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892, (301) 594-8886, sanoviche@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Short-Term Institutional Research Training Grant Review.
Date: May 14, 2026.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Srihari Seshadri, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Dr. (RK2), Bethesda, MD 20817, (301) 594-4738, srihari.seshadri@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Bacterial Virulence.
Date: May 14, 2026.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II 6701, Rockledge Drive Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Louis A. Rosenthal, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 669-5070, rosenthalla@niaid.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Mentored Career Development Awards: Epidemiology and Population Sciences Panel B.
Date: May 14, 2026.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Devon Rene Oskvig, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402-6965, devon.oskvig@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; NARCH Planning Grants.
Date: May 14, 2026.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Susan Gillmor, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 762-3076, susan.gillmor@nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated Review Group Maximizing Investigators' Research Award A Study Section.
Date: May 18-19, 2026.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mollie Kim Manier, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0510, mollie.manier@nih.gov.
( printed page 21011) Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel; Early Phase Clinical Trials (Pharma/Device and Blueprint MedTech Translator).
Date: May 19, 2026.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Victor Henriquez, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20892, (301) 435-0813, victor.henriquez@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)
Dated: April 14, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-07580 Filed 4-17-26; 8:45 am]
BILLING CODE 4167-05-P
Published Document: 2026-07580 (91 FR 21010)
Named provisions
Related changes
Get daily alerts for FR: National Institutes of Health
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Health and Human Services Department.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FR: National Institutes of Health publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.